BioXcel Therapeutics, Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
BioXcel Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • BioXcel Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $77K, a 4.94% decline year-over-year.
  • BioXcel Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $312K, a 4.59% decline year-over-year.
  • BioXcel Therapeutics, Inc. annual Depreciation for 2023 was $318K, a 2.75% decline from 2022.
  • BioXcel Therapeutics, Inc. annual Depreciation for 2022 was $327K, a 10.1% increase from 2021.
  • BioXcel Therapeutics, Inc. annual Depreciation for 2021 was $297K, a 58% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $318K -$9K -2.75% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 $327K +$30K +10.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $297K +$109K +58% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $188K +$33K +21.3% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-12
2019 $155K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.